Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and their associated anionic components serve as a fundamental structural barrier and a critical target for various antimicrobial therapies. Unlike mammalian cell membranes, which are predominantly composed of neutral zwitterionic phospholipids like phosphatidylcholine, microbial membranes are enriched with negatively charged (anionic) phospholipids such as phosphatidylglycerol and cardiolipin (Epand et al., 2016, PMID: 27133774). In addition to these lipids, Gram-negative bacteria possess lipopolysaccharides (LPS) and Gram-positive bacteria contain teichoic acids, both of which contribute to a high density of phosphate groups and a strong negative surface charge (Yeaman & Yount, 2003, PMID: 12615781). This distinct biochemical profile allows for the selective targeting of microbes by cationic antimicrobial peptides (AMPs) and lipopeptides, which utilize electrostatic attraction to bind the cell surface. Once bound, these agents can insert into the bilayer, causing physical disruption, pore formation, and rapid depolarization of the membrane potential, ultimately leading to cell death (Malanovic & Lohner, 2016, PMID: 27133774). This mechanism is particularly effective against multi-drug resistant pathogens, although therapeutic challenges include maintaining selectivity to avoid toxicity in human cells.
Drugs typically interact via electrostatic attraction to the negatively charged membrane surface, followed by hydrophobic insertion into the lipid bilayer, leading to pore formation, membrane depolarization, and leakage of intracellular contents.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane anionic phospholipids and phosphate-containing components (Microbial cell membrane).